Please use this identifier to cite or link to this item:
Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C.
|Title:||Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C.|
|Authors:||Thomas, William L Jr|
Hospenthal, Duane R.
|Issue Date:||Aug 2003|
|Abstract:||Pegylated interferons have recently been approved for treatment of hepatitis C. The safety of these formulations is reported to be similar to that of non-pegylated interferon. We present two patients who experienced exacerbations of their liver disease following administration of pegylated interferon alfa-2b. Vigilant monitoring of patients treated with these new agents is recommended.|
|Appears in Collections:||Hawaii Medical Journal Articles For 2003|
Items in eVols are protected by copyright, with all rights reserved, unless otherwise indicated.